{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:38:07Z","timestamp":1792874287533,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["ZD2021028"],"award-info":[{"award-number":["ZD2021028"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbrc.2026.154602","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:07:15Z","timestamp":1790035635000},"page":"154602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation"],"prefix":"10.1016","volume":"839","author":[{"given":"Shuangyu","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9570-2891","authenticated-orcid":false,"given":"Qingyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbrc.2026.154602_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154602_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1702900","article-title":"Abiraterone for prostate cancer not previously treated with hormone therapy","volume":"377","author":"James","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with standard first-line therapy in metastatic prostate cancer","volume":"381","author":"Davis","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154602_bib4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa2119115","article-title":"Darolutamide and survival in metastatic, hormone-sensitive prostate cancer","volume":"386","author":"Smith","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154602_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.bbrc.2026.154602_bib8","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1200\/JCO.20.01035","article-title":"Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration","volume":"38","author":"Abida","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bbrc.2026.154602_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2012.05.036","article-title":"Systematic functional prioritization of protein posttranslational modifications","volume":"150","author":"Beltrao","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13046-019-1358-x","article-title":"DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation","volume":"38","author":"Cui","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154602_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41418-022-00951-y","article-title":"ERK1\/2 inhibits cullin 3\/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression","volume":"29","author":"Fan","year":"2022","journal-title":"Cell Death Differ."},{"issue":"45","key":"10.1016\/j.bbrc.2026.154602_bib13","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1038\/onc.2017.225","article-title":"Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer","volume":"36","author":"Ashikari","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib14","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","article-title":"SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis","volume":"12","author":"Shangguan","year":"2021","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154602_bib15","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1093\/nar\/gkae653","article-title":"Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells","volume":"52","author":"Launonen","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154602_bib16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/labinvest.2008.97","article-title":"Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer","volume":"88","author":"Fiorentino","year":"2008","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119741","article-title":"Inhibition of \u03b4-catenin palmitoylation slows the progression of prostate cancer","volume":"1871","author":"Wang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154602_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ccell.2025.04.002","article-title":"KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy","volume":"43","author":"Guo","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1158\/0008-5472.CAN-11-3004","article-title":"Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy","volume":"72","author":"Sun","year":"2012","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154602_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/2159-8290.CD-13-0108","article-title":"A hormone-DNA repair circuit governs the response to genotoxic insult","volume":"3","author":"Goodwin","year":"2013","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib22","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/s41467-025-61560-0","article-title":"YY1 enhances HIF-1\u03b1 stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12943-025-02436-1","article-title":"Targeting CXCR2 in prostate cancer cells can block CD47-SIRP\u03b1 interaction and reverse M2 macrophage polarization in the TME","volume":"24","author":"Sun","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.molcel.2025.02.004","article-title":"SUMO4 promotes SUMO deconjugation required for DNA double-strand-break repair","volume":"85","author":"Garvin","year":"2025","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154602_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nsmb.3366","article-title":"Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation","volume":"24","author":"Hendriks","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"37","key":"10.1016\/j.bbrc.2026.154602_bib26","doi-asserted-by":"crossref","first-page":"31195","DOI":"10.1074\/jbc.M112.395210","article-title":"The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline\/glycine residues of synergy control motifs","volume":"287","author":"Mukherjee","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154602_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/me.2008-0219","article-title":"SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells","volume":"23","author":"Kaikkonen","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"33","key":"10.1016\/j.bbrc.2026.154602_bib28","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.M110.134874","article-title":"SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms","volume":"285","author":"Bawa-Khalfe","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.ajpath.2012.01.026","article-title":"PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21","volume":"180","author":"Hoefer","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.bbrc.2026.154602_bib30","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1093\/nar\/gku543","article-title":"SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner","volume":"42","author":"Sutinen","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/nar\/gku1375","article-title":"SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin","volume":"43","author":"Toropainen","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"27","key":"10.1016\/j.bbrc.2026.154602_bib32","doi-asserted-by":"crossref","first-page":"41110","DOI":"10.18632\/oncotarget.9002","article-title":"SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154602_bib33","first-page":"795","article-title":"Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer","volume":"14","author":"Oh","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbrc.2026.154602_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ncomms1919","article-title":"SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane","volume":"3","author":"Huang","year":"2012","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154602_bib35","doi-asserted-by":"crossref","first-page":"17651","DOI":"10.18632\/oncotarget.13283","article-title":"SENP1 regulates PTEN stability to dictate prostate cancer development","volume":"8","author":"Bawa-Khalfe","year":"2017","journal-title":"Oncotarget"},{"issue":"24 Pt B","key":"10.1016\/j.bbrc.2026.154602_bib36","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.febslet.2015.11.028","article-title":"Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis","volume":"589","author":"Choi","year":"2015","journal-title":"FEBS Lett."},{"issue":"7275","key":"10.1016\/j.bbrc.2026.154602_bib37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature08657","article-title":"Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks","volume":"462","author":"Galanty","year":"2009","journal-title":"Nature"},{"issue":"7275","key":"10.1016\/j.bbrc.2026.154602_bib38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nature08593","article-title":"The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress","volume":"462","author":"Morris","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154602_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cell.2012.10.021","article-title":"Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair","volume":"151","author":"Psakhye","year":"2012","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154602_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186871","article-title":"SPOP mutations increase PARP inhibitor sensitivity via CK2\/PIAS1\/SPOP axis in prostate cancer","volume":"10","author":"Zhang","year":"2025","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154602_bib41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb2112","article-title":"SUMOylation of the GTPase Rac1 is required for optimal cell migration","volume":"12","author":"Castillo-Lluva","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154602_bib42","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1038\/s41388-018-0641-1","article-title":"Sumoylation of Flotillin-1 promotes EMT in metastatic prostate cancer by suppressing snail degradation","volume":"38","author":"Jang","year":"2019","journal-title":"Oncogene"},{"issue":"58","key":"10.1016\/j.bbrc.2026.154602_bib43","doi-asserted-by":"crossref","first-page":"97703","DOI":"10.18632\/oncotarget.20097","article-title":"Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGF\u03b2 stimulation in cancer","volume":"8","author":"Gudey","year":"2017","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bbrc.2026.154602_bib44","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/MCB.00753-12","article-title":"Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus","volume":"32","author":"Rytinki","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.bbrc.2026.154602_bib45","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.18632\/oncotarget.2658","article-title":"PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells","volume":"5","author":"Puhr","year":"2014","journal-title":"Oncotarget"},{"issue":"5716","key":"10.1016\/j.bbrc.2026.154602_bib46","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1126\/science.1105654","article-title":"An acylation cycle regulates localization and activity of palmitoylated ras isoforms","volume":"307","author":"Rocks","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154602_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11306","article-title":"ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization","volume":"4","author":"Lin","year":"2015","journal-title":"eLife"},{"issue":"13","key":"10.1016\/j.bbrc.2026.154602_bib48","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1128\/MCB.01354-09","article-title":"Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane","volume":"30","author":"Razandi","year":"2010","journal-title":"Mol. Cell Biol."},{"issue":"41","key":"10.1016\/j.bbrc.2026.154602_bib49","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.M111.265124","article-title":"Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells","volume":"286","author":"Yang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154602_bib50","first-page":"2788","article-title":"Palmitoylome profiling indicates that androgens regulate the palmitoylation of \u03b1-tubulin in prostate cancer-derived LNCaP cells and supernatants","volume":"42","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154602_bib51","first-page":"227","article-title":"[Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells]","volume":"52","author":"Li","year":"2020","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.bbrc.2026.154602_bib52","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.2147\/OTT.S193480","article-title":"Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells","volume":"12","author":"Cui","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"26","key":"10.1016\/j.bbrc.2026.154602_bib53","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41388-023-02718-2","article-title":"Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer","volume":"42","author":"Lin","year":"2023","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154602_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41416-025-02938-1","article-title":"The long noncoding RNA lncZBTB10 facilitates AR function via S-palmitoylation to promote prostate cancer progression and abiraterone resistance","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10.1016\/j.bbrc.2026.154602_bib55","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1038\/s41388-020-1243-2","article-title":"Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of rho GTPases","volume":"39","author":"De Piano","year":"2020","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbrc.2026.154602_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/21541248.2020.1826781","article-title":"Exploring a role for fatty acid synthase in prostate cancer cell migration","volume":"12","author":"De Piano","year":"2021","journal-title":"Small GTPases"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154602_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2016.04.003","article-title":"Inhibition of DHHC20-Mediated EGFR palmitoylation creates a dependence on EGFR signaling","volume":"62","author":"Runkle","year":"2016","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.bbrc.2026.154602_bib58","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1158\/0008-5472.CAN-04-1574","article-title":"The palmitoylation of metastasis suppressor KAI1\/CD82 is important for its motility- and invasiveness-inhibitory activity","volume":"64","author":"Zhou","year":"2004","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154602_bib59","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/pros.23796","article-title":"Dietary palmitate cooperates with Src kinase to promote prostate tumor progression","volume":"79","author":"Kim","year":"2019","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1764192","article-title":"Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles","volume":"9","author":"Mariscal","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib61","article-title":"ZDHHC2-Dependent palmitoylation dictates ferroptosis and castration sensitivity in prostate cancer via controlling ACSL4 degradation and lipid peroxidation","volume":"13","author":"Shao","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1039\/D0CB00157K","article-title":"A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions","volume":"2","author":"Yao","year":"2021","journal-title":"RSC Chem. Biol."},{"issue":"39","key":"10.1016\/j.bbrc.2026.154602_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2514948122","article-title":"PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors","volume":"122","author":"Chowdhury","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154602_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.4339","article-title":"New links between S-acylation and cancer","volume":"233","author":"Greaves","year":"2014","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154602_bib65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/emboj.2011.446","article-title":"A palmitoylation switch mechanism regulates Rac1 function and membrane organization","volume":"31","author":"Navarro-L\u00e9rida","year":"2012","journal-title":"Embo j"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154602_bib66","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1158\/2767-9764.CRC-25-0243","article-title":"A first-in-human study of the SUMOylation inhibitor subasumstat in patients with advanced\/metastatic solid tumors or relapsed\/refractory hematologic malignancies","volume":"5","author":"Juric","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"323","key":"10.1016\/j.bbrc.2026.154602_bib67","doi-asserted-by":"crossref","first-page":"rs2","DOI":"10.1126\/scisignal.2005146","article-title":"Proteome-wide identification of SUMO2 modification sites","volume":"7","author":"Tammsalu","year":"2014","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154602_bib68","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","article-title":"Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer","volume":"64","author":"Langston","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154602_bib69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nchembio.362","article-title":"Small-molecule inhibition of APT1 affects ras localization and signaling","volume":"6","author":"Dekker","year":"2010","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154602_bib70","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846666","article-title":"Protein palmitoylation and cancer","volume":"19","author":"Ko","year":"2018","journal-title":"EMBO Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:57:31Z","timestamp":1792871851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26013689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"alternative-id":["S0006291X26013689"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154602","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154602"}}